Eupraxia Pharmaceuticals (EPRX) Return on Equity [ROE] (2024 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Return on Equity [ROE] of -40.97% for the quarter ended Jun 30, 2026, up 79.45 percentage points from -120.42% a year earlier and up 0.44 percentage points from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals posted Return on Equity [ROE] of -64.99%, up 101.20 percentage points from the prior year.
- By year, Return on Equity [ROE] came in at -166.19% in the year ended Dec 31, 2024 (+547.03 pp) and -713.22% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Return on Equity [ROE] in data going back to the quarter ended Mar 31, 2024.
- Year over year, Return on Equity [ROE] has now increased in each of the last six quarters, with an average year-over-year change of +122.01 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -41.41% (quarter ended Mar 31, 2026), -43.21% (quarter ended Dec 31, 2025) and -54.68% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | -40.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.97% |
| Mar 31, 2026 | -41.41% |
| Dec 31, 2025 | -43.21% |
| Sep 30, 2025 | -54.68% |
| Jun 30, 2025 | -120.42% |
| Mar 31, 2025 | -94.23% |
| Dec 31, 2024 | -136.62% |
| Sep 30, 2024 | -271.14% |
| Jun 30, 2024 | -177.05% |
| Mar 31, 2024 | -327.53% |
API Access
Eupraxia Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();